Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial.
Kojima K, Kamata Y, Shimizu T, Sato S, Suzuki S, Takanashi Y, Hojo S, Yoshino T, Fuchida S, Tamura T, Minabe M, Kodama T, Kessoku T, Oyamada S. Kojima K, et al. Among authors: sato s. J Periodontal Res. 2024 Dec;59(6):1162-1174. doi: 10.1111/jre.13310. Epub 2024 Jun 9. J Periodontal Res. 2024. PMID: 38853125 Free PMC article. Clinical Trial.
Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial.
Kamata Y, Kessoku T, Shimizu T, Sato S, Kobayashi T, Kurihashi T, Morozumi T, Iwasaki T, Takashiba S, Hatanaka K, Hamada N, Kodama T, Higurashi T, Taguri M, Yoneda M, Usuda H, Wada K, Nakajima A, Minabe M. Kamata Y, et al. Among authors: sato s. Clin Transl Gastroenterol. 2022 Nov 1;13(11):e00520. doi: 10.14309/ctg.0000000000000520. Clin Transl Gastroenterol. 2022. PMID: 36000999 Free PMC article. Clinical Trial.
Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
Kamata Y, Kessoku T, Shimizu T, Kobayashi T, Kurihashi T, Sato S, Kuraji S, Aoyama N, Iwasaki T, Takashiba S, Hamada N, Kodama T, Tamura T, Ino S, Higurashi T, Taguri M, Yamanaka T, Yoneda M, Usuda H, Wada K, Nakajima A, Minabe M. Kamata Y, et al. Among authors: sato s. Trials. 2020 Mar 23;21(1):291. doi: 10.1186/s13063-020-4201-y. Trials. 2020. PMID: 32293522 Free PMC article. Clinical Trial.
Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study.
Omori Y, Matsukuma S, Kawa M, Ishimitsu K, Kawaoka T, Akiyama N, Tokuno K, Fujita Y, Sato S, Yamamoto S. Omori Y, et al. Among authors: sato s. Int J Colorectal Dis. 2025 Jan 13;40(1):11. doi: 10.1007/s00384-024-04798-2. Int J Colorectal Dis. 2025. PMID: 39800823
Covalent Plant Natural Product that Potentiates Antitumor Immunity.
Takemoto M, Delghandi S, Abo M, Yurimoto K, Odagi M, Singh VP, Wang J, Nakagawa R, Sato SI, Takemoto Y, Farrag AMAS, Kawaguchi Y, Nagasawa K, Honjo T, Chamoto K, Uesugi M. Takemoto M, et al. Among authors: sato si. J Am Chem Soc. 2025 Jan 10. doi: 10.1021/jacs.4c17837. Online ahead of print. J Am Chem Soc. 2025. PMID: 39794153
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study.
Shindo T, Hashimoto K, Kenuka T, Miyamoto S, Hiyama Y, Fukuta F, Kunishima Y, Okada M, Matsukawa M, Kato R, Senda M, Wanifuchi A, Sato S, Kobayashi K, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: sato s. J Geriatr Oncol. 2025 Jan 9;16(2):102183. doi: 10.1016/j.jgo.2024.102183. Online ahead of print. J Geriatr Oncol. 2025. PMID: 39793527
12,288 results
You have reached the last available page of results. Please see the User Guide for more information.